Diabetes

Liraglutide increases heart rate in T2DM with stable CAD

(HealthDay)—Liraglutide increases heart rate (HR) and reduces heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD), according to a study ...

Oncology & Cancer

Obesity linked to improved survival in kidney cancer

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival ...

Neuroscience

Research indicates food craving is 'hard-wired' in the brain

An international group of researchers have found that food craving activates different brain networks between obese and normal weight patients. This indicates that the tendency to want food may be 'hard-wired' into the brain ...

Diseases, Conditions, Syndromes

Weight loss benefits NASH, no matter how it's done

(HealthDay)—Weight loss can improve nonalcoholic steatohepatitis (NASH) in obese or overweight people, whether excess pounds are shed through lifestyle changes or weight-loss surgery, according to research published in ...

Diabetes

Diabetes drug helps people lose weight: study

Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, helped obese people lose an average of 18 pounds (eight kilograms), a yearlong study said Wednesday.

Cardiology

Survival rates higher in obese heart failure patients

Patients who were obese before developing heart failure lived longer than normal weight patients with the same condition according to a new study in the Journal of the American College of Cardiology that examined the "obesity ...

page 3 from 8